168 related articles for article (PubMed ID: 25297773)
1. [Thrombosis and DIC in hematological malignancies].
Asakura H
Rinsho Ketsueki; 2014 Oct; 55(10):2066-75. PubMed ID: 25297773
[No Abstract] [Full Text] [Related]
2. [Disseminated intravascular coagulation in malignant neoplasms].
Kato A
Rinsho Ketsueki; 2010 Jan; 51(1):37-43. PubMed ID: 20134138
[No Abstract] [Full Text] [Related]
3. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
[TBL] [Abstract][Full Text] [Related]
4. Intravascular clotting activation and bleeding in patients with hematologic malignancies.
Tallman MS; Kwaan HC
Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies].
Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M
Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878
[TBL] [Abstract][Full Text] [Related]
6. The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.
Barbui T; Finazzi G; Falanga A
Blood; 1998 May; 91(9):3093-102. PubMed ID: 9558362
[No Abstract] [Full Text] [Related]
7. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin in the prophylaxis and treatment of disseminated intravascular coagulation in acute promyelocytic leukemia.
Gillis S; Dann EJ; Eldor A
Eur J Haematol; 1995 Jan; 54(1):59-60. PubMed ID: 7859878
[No Abstract] [Full Text] [Related]
9. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy.
Incerpi MH; Miller DA; Posen R; Byrne JD
Obstet Gynecol; 1997 May; 89(5 Pt 2):826-8. PubMed ID: 9166337
[TBL] [Abstract][Full Text] [Related]
11. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
[TBL] [Abstract][Full Text] [Related]
12. [The effect of the recombinant thrombomodulin which merged to hematological malignancy].
Kawasugi K
Rinsho Byori; 2011 Feb; Suppl 147():181-7. PubMed ID: 21761769
[No Abstract] [Full Text] [Related]
13. [Treatment of malignant hemopathies with all transretinoic acid].
Fenaux P; Chomienne C
Presse Med; 1997 Oct; 26(29):1399-405. PubMed ID: 9404351
[No Abstract] [Full Text] [Related]
14. [Diagnosis and management of DIC complicated by hematological malignancies].
Ikezoe T
Rinsho Ketsueki; 2016; 57(10):2136-2144. PubMed ID: 27795523
[TBL] [Abstract][Full Text] [Related]
15. ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin.
Ohshiro M; Kuroda J; Kobayashi Y; Akaogi T; Kawata E; Uoshima N; Kamitsuji Y; Kaneko H; Shimura K; Shimazaki C; Murakami S; Hatsuse M; Okano A; Kobayashi T; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M
Am J Hematol; 2012 Jan; 87(1):116-9. PubMed ID: 21989545
[No Abstract] [Full Text] [Related]
16. [Cutting edge of diagnosis and treatment of disseminated intravascular coagulation].
Seki Y
Rinsho Ketsueki; 2022; 63(5):441-453. PubMed ID: 35662170
[TBL] [Abstract][Full Text] [Related]
17. The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.
Kwaan HC; Cull EH
Best Pract Res Clin Haematol; 2014 Mar; 27(1):11-8. PubMed ID: 24907013
[TBL] [Abstract][Full Text] [Related]
18. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage.
Hashimoto S; Koike T; Tatewaki W; Seki Y; Sato N; Azegami T; Tsukada N; Takahashi H; Kimura H; Ueno M
Leukemia; 1994 Jul; 8(7):1113-5. PubMed ID: 8035603
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of recombinant human soluble thrombomodulin in induction therapy for acute promyelocytic leukemia.
Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H
Thromb Res; 2021 Jun; 202():173-175. PubMed ID: 33866226
[No Abstract] [Full Text] [Related]
20. [Acute promyelocytic leukemia associated with hemophagocytic syndrome].
Jinta M; Arai A; Yamamoto K; Sakashita C; Fukuda T; Miu T; Koyama T; Murakami N; Miura O
Rinsho Ketsueki; 2007 Apr; 48(4):310-4. PubMed ID: 17515122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]